REMEDIUMREMEDIUM1561-59362658-3534Joint-Stock Company Chicot171210.32687/1561-5936-2024-28-2-139-144Original ArticleProviding pharmaceutical care during coronavirus infection (COVID-19)MotygullinaLeysan I.mleisi20@mail.ruTukhbatullinaRuzaliya G.ruzaliya.tukhbatullina@kazangmu.ruKazan State Medical University, Kazan, Russia15122024213914415102025Copyright © 2024,2024This review examines the current state of pharmaceutical care for the population in conditions of coronavirus infection (COVID-19). The authors analyze the history of the pandemic, the basic principles of the concept of pharmaceutical care, Russian and foreign experience in providing pharmaceutical care to the population during the pandemic. However, the problem of developing organizational and economic approaches to research the availability and quality of pharmaceutical care to the population with acute respiratory viral infections in conditions of COVID-19 at the regional level requires further study.acute respiratory viral infectionscoronavirus infectionCOVID-19pharmaceutical caretreatmentreviewострые респираторные вирусные инфекциикоронавирусная инфекцияCOVID-19фармацевтическая помощьлечениеобзор1.Tihonova E. P., Kuz'mina T. Yu., Andronova N. V. et al. To study the effectiveness of antiviral drugs (umifenovir, triazavirin) against acute respiratory viral infections. Kazanskij medicinskij zhurnal. 2018;99(2):215–223. (In Russ.)2.Skvorcov V. V., Orlov O. V. Flu and SARS. Medicinskaja sestra. 2016;(7):3–6. (In Russ.)3.Gazieva Z.Sh., Tobolkina V. A., Firsenko N. P. et al. Investigation of the range of medicines with antiviral effect. Universitetskaja medicina Urala. 2019;(4):32–34. (In Russ.)4.Malinnikova E. Yu. A new coronavirus infection. Today's view of the pandemic of the 21st century. Infekcionnye bolezni: novosti, mnenija, obuchenie. 2020;9(2):18–32. (In Russ.)5.Umakanthan S., Sahu P., Ranade A. V. et al. Origin, transmission, diagnosis and management of coronavirus disease 2019 (COVID-19). Postgraduate Med. J. 2020;96(1142):753–758.6.Han Q., Lin Q., Jin S., You L. Recent insights into 2019-nCoV: a brief but comprehensive review. J. Infect. 2020;80(4):373–377.7.Mironova T. K. The right to medical care and provision of medicines. Voprosy rossijskogo i mezhdunarodnogo prava. 2016;(5):97–112. (In Russ.)8.Hepler C. D., Strand L. M. Opportunities and responsibilities in pharmaceutical care. Am. J. Hosp. Pharm. 1990;47(3):533–543.9.Dremova N. B., Ovod A. I., Korzhavyh E. A., Litvinova T. M. Pharmaceutical care: the term and concept. Farmacija. 2005;(2):37–45. (In Russ.)10.Litvinova T. M. Marketing research of pharmaceutical care for breast cancer patients: avtoref. dis. … kand. farm. nauk: 15.01.01. Kursk, 2001. 24 p. (In Russ.)11.Semenova A. D. Development of organizational technologies for pharmaceutical care for outpatient patients (using the example of diabetes mellitus): dis. … kand. farm. nauk: 14.04.03. Perm', 2014. 263 p. (In Russ.)12.Kozub O. V. Identification of features and modeling of pharmaceutical care for patients with migraine and tension headache: dis. … kand. farm. nauk: 14.04.03. Moscow, 2015. 195 p. (In Russ.)13.Trubina L. V. Development of scientific and methodological approaches to pharmaceutical care for the prevention of infections carried by ixodic ticks: dis. … kand. farm. nauk: 14.04.03. Moscow, 2015. 167 p. (In Russ.)14.Gazieva Z.Sh., Tobolkina V. A., Firsenko N. P., Goncharova K. K. Research of the range of medicines with antiviral effect. Universitetskaja medicina Urala. 2020;6(2):32–34. (In Russ.)15.Savina E. A. Marketing research of the antiviral drugs market. Bjulleten' medicinskih internet-konferencij. 2015;7(5):787. (In Russ.)16.Gubarev Ya. B., Slobodenjuk E. V. Comparative marketing analysis of the pharmaceutical market of medicines for the treatment of influenza and acute respiratory viral infection in the Far Eastern Federal District of the Russian Federation. Dal'nevostochnyj medicinskij zhurnal. 2019;(4):20–23. (In Russ.)17.Kononenko V. S. Marketing research of the antiviral drugs market. Bjulleten' medicinskih internet-konferencij. 2017;7(6):1235. (In Russ.)18.Spichak I. V., Murashko Yu. I., Varenyh G. V. Comparative marketing analysis of the pharmaceutical market of medicines used in the treatment of acute respiratory viral infections, including in pregnant women. Vestnik VGU, Serija: Himija. Biologija. Farmacija. 2017;(2):112–117. (In Russ.)19.Pokachajlo L. I. Marketing analysis of the market of antiviral drugs for oral administration for the prevention and treatment of influenza. Recept. 2017;20(6):639–646. (In Russ.)20.Goroshko N. V., Pacala SV., Emel'janova E. K. The COVID-19 vaccine market as a new segment of the global vaccine market. Vestnik Kemerovskogo gosudarstvennogo universiteta. Serija: Politicheskie, sociologicheskie i jekonomicheskie nauki. 2021;6(2):178–190. (In Russ.)21.Roshhina L. L., Polovinko A. E. Preventive immunization with influenza vaccines. Innovacionnye tehnologii v farmacii. 2021;(8):274–283. (In Russ.)22.Belikova Yu. A., Samsonov Yu. V., Abakushina E. V. Modern vaccines and coronavirus infections. Issledovanija i praktika v medicine. 2020;7(4):135–154. (In Russ.)23.Somova M. N., Mubarakshina O. A., Atorceva A. A. et al. Pharmacoconomical assessment of various treatment regimens for the new coronavirus infection COVID-19 in a hospital setting. In: Aktual'nye voprosy lekarstvennogo obespechenija i kontrol' kachestva preparatov. Voronez, 2021:35–39. (In Russ.)24.Kovalenko A. V., Halimova A. A. Economic aspects of ensuring drug safety in Russia in the context of the coronavirus pandemic. In: European research. Sbornik statej XXX Mezhdunarodnoj nauchno-prakticheskoj konferencii. Penza, 2021:49–51. (In Russ.)25.Bazhenova S. A., Grammova E. A. An economic overview of the Russian pharmaceutical market during the pandemic crisis. Remedium. 2021;25(4):57–60. (In Russ.)26.Prosalova V. S., Getman O. V., Falaleev M. A., Sitdikova N. A. Development of the Russian pharmaceutical market in the context of the spread of coronavirus infection. Azimut nauchnyh issledovanij: jekonomika i upravlenie. 2021;10(1):259–263. (In Russ.)27.Esipov A. V., Pavlov A. I., Nemytin Yu. V. et al. Organization of specialized medical care for patients with the new coronavirus infection COVID-19 on the basis of a multidisciplinary hospital. Fizicheskaja i reabilitacionnaja medicina, medicinskaja reabilitacija. 2021;3(1):163–169. (In Russ.)28.Malinnikova E. Yu. A new coronavirus infection. Today's view of the pandemic of the XXI century COVID-19. Infekcionnye bolezni: novosti, mnenija, obuchenie. 2020;9(2):18–32. (In Russ.)29.Murav'eva A.A., Mihajlova Yu. V., Shikina I. B. Organizational measures for the provision of medical care to patients with the new coronavirus infection COVID-19 in the Stavropol Territory. Sovremennye problemy zdravoohranenija i medicinskoj statistiki. 2020;(4):382–396. (In Russ.)30.Hasan M. J., Nead J. The pandemic COVID-19 and the auspicious role of frontier pharmacists against this global threat. Pharmacol. Pharm. 2020;11(9):209–225.31.Bukhari N., Rasheed H., Nayyer B., Babar Z. U. Pharmacists at the frontline beating the COVID-19 pandemic. J. Pharm. Policy Pract. 2020;13(1):1–4.32.Liu S., Luo P., Tang M. et al. Providing pharmacy services during the coronavirus pandemic. Int. J. Clin. Pharm. 2020;42(2):299–304.33.Sarybayev M. S., Guo Haoqi. China’s contribution to the fight against the COVID-19 pandemic. Халы?аралы? ?атынастар және халы?аралы? ???ы? сериясы. 2022;(4):32–39.34.Chzhao Zhun, Sjuj Fjencaj. Advantages of the Chinese model: China's experience in the fight against coronavirus in the Russian press. Mir russkogovorjashhih stran. 2021;(1):17–32. (In Russ.)35.Austin Z., Gregory P. Resilience in the time of pandemic: The experience of community pharmacists during COVID-19. Res. Soc. Adm. Pharm. 2021;17(1):1867–1875.36.Yoo J. Y., Dutra S. V.O., Fanfan D. et al. Comparative analysis of COVID-19 guidelines from six countries: a qualitative study on the US, China, South Korea, the UK, Brazil, and Haiti. BMC Public Health. 2020;20(1):1853.37.Krivous L. S., Kostenko N. L., Rodionov E. O. The problem of the impact of stress on the professional activities of pharmaceutical workers of the Russian Ministry of Defense during the COVID-19 pandemic and ways to solve it. Izvestija Rossijskoj Voenno-meditsinskoj akademii. 2022;41(2):235–239. (In Russ.)38.Pak T. V., Borovikova E. A., Galkina G. A. et al. Features of the work of pharmacy staff in the context of the COVID-19 pandemic. Mediko-farmacevticheskij zhurnal «Pul's». 2021;23(5):35–41. (In Russ.)39.Klompas M., Branson R., Eichenwald E. C. et al. Strategies to prevent ventilator-associated pneumonia in acute care hospitals: 2014 update. Infect. Control Hosp. Epidemiol. 2014;35(8):915–936.40.Bahareva A. V., Roshhin D. O. Мedical and social aspects of increasing the availability of medicines in the context of the need for prevention and treatment of diseases that pose a danger to others. Problemy social'noj gigieny, zdravoohranenija i istorii meditsiny. 2021;29(6):1446–1450. (In Russ.)41.Motygullina L. I., Tuhbatullina R. G. Comparative analysis of Temporary methodological recommendations for the prevention, diagnosis and treatment of new coronavirus infection. Remedium. 2023;27(1):12–16. (In Russ.)